Preclinical Target & Biomarker Identification & Validation

Preclinical Target & Biomarker Identification & Validation

Preclinical target and biomarker identification and validation play a crucial role in the drug discovery process, as they help identify potential therapeutic targets and monitor the efficacy of drugs in development. Our services in this area are designed to provide the necessary tools and techniques to support your research goals.

Our services include:

  • Tissue Sourcing & Cell Isolation: Our tissue sourcing and cell isolation services provide high-quality fresh or formalin-fixed human tissues, as well as advanced cell isolation techniques, such as enzymatic or mechanical tissue dissociation and magnetic bead-based cell separation.
  • Clinical Sample Processing: We offer a range of clinical sample processing techniques, including sample storage and transport, to ensure the quality and integrity of your samples for downstream analysis.
  • Genomics & Gene Expression: Our genomics and gene expression services utilize advanced techniques such as next-generation sequencing (NGS) and quantitative polymerase chain reaction (qPCR) to provide insight into the genetic basis of disease and the molecular mechanisms of drug action.
  • Immunoassays: Our immunoassays utilize techniques such as ELISA, Western blotting, and immunoprecipitation to measure the levels of specific proteins in biological samples, providing important information about disease state and drug efficacy.
  • Cell-based Assays: Our cell-based assays use techniques such as cell proliferation assays, apoptosis assays, and functional assays to study the cellular and molecular responses to disease and drug treatments in a controlled environment.

At BIOMEX, we are dedicated to providing the necessary tools and techniques for advancing your preclinical target and biomarker identification and validation efforts. Contact us to learn more about how we can support your research.

This site is registered on wpml.org as a development site.